IP Library Granted Patent US 8,197,801
Granted Patent B2
US 8,197,801 · App. 11/963,244 · Granted Jun 12, 2012

Use of compounds for the preservation of the human or animal body and compositions comprising same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,197,801
App. No.
11/963,244
Granted
Jun 12, 2012
Kind
B2
Abstract

The present invention relates to the use of at least one compound of formula (I) R—(OCH 2 )n—OR′ in which R and R′, identical or different, represent a linear or branched alkyl radical comprising 1 to 5 carbon atoms and n is an index with a value comprised between 1 and 8, and/or at least one dialdehyde acetal type compound for the preservation of the human or animal body and/or the embalming of dead bodies. It also relates to a composition comprising same and a process for preserving a human or animal body and/or embalming a dead body comprising the administration of the composition to the dead body in particular by injection, perfusion, immersion or topical application.

Claims (10)

1. A process for preserving a dead human or animal body and/or embalming a dead human or animal body comprising the administration to said dead body of a composition comprising at least one compound of formula

(I) R—(OCH 2 ) n —OR′ wherein R and R′, identical or different, represent a linear or branched alkyl radical comprising 1 to 5 carbon atoms and n is an index with a value comprised between 1 and 8.

2. The process according to claim 1 , characterized in that the composition is injected into said body by intra-arterial route.

3. The process according to claim 1 , characterized in that the composition is perfused into said body.

4. The process according to claim 1 , characterized in that said body is immersed in the composition.

5. The process according to claim 1 , characterized in that the composition is applied to said body by topical route.

6. The process according to claim 1 , wherein the at least one compound is selected from the group consisting of CH 3 —(OCH 2 )—OCH 3 , CH 3 —(OCH 2 ) 2 —OCH 3 , CH 3 —(OCH 2 ) 3 —OCH 3 , CH 3 —(OCH 2 ) 4 —OCH 3 , CH 3 —(OCH 2 ) 5 —OCH 3 , CH 3 —(OCH 2 ) 6 —OCH 3 , CH 3 —(OCH 2 ) 7 OCH 3 , CH 3 —(OCH 2 ) 8 —OCH 3 , C 2 H 5 —(OCH 2 )—OC 2 H 5 , C 2 H 5 —(OCH 2 ) 2 —OC 2 H 5 , C 2 H 5 —(OCH 2 ) 3 —OC 2 H 5 , C 2 H 5 —(OCH 2 ) 4 —OC 2 H 5 , C 2 H 5 —(OCH 2 ) 5 —OC 2 H 5 , C 2 H 5 —(OCH 2 ) 6 —OC 2 H 5 , C 2 H 5 —(OCH 2 ) 7 —OC 2 H 5 , C 2 H 5 —(OCH 2 ) 8 —OC 2 H 5 , C 4 H 9 —(OCH 2 )—OC 4 H 9 , CH 3 —(OCH 2 )—OC 2 H 5 .

7. The process according to claim 1 , wherein the at least one compound is of formula (I) and has a symmetrical structure.

8. The process according to claim 1 , wherein the at least one compound is a mixture of compounds of formula CH 3 —(OCH 2 ) n —OCH 3 where n is 2-8.

9. The process according to claim 1 , wherein the at least one compound is a mixture of compounds of formula C 2 H 5 —(OCH 2 ) n —OC 2 H 5 where n is 1-8.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2025
From: ARKEMA FRANCE
To: CHEMCOM INVESTMENTS B.V.
Reel/Frame 073164/0387 →
CHANGE OF ADDRESS Recorded Jul 4, 2025
From: ARKEMA FRANCE
To: ARKEMA FRANCE
Reel/Frame 071814/0739 →